Stevens Capital Management LP Has $1.07 Million Stock Position in The Clorox Company (NYSE:CLX)

Stevens Capital Management LP grew its stake in shares of The Clorox Company (NYSE:CLX) by 32.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,595 shares of the company’s stock after buying an additional 1,602 shares during the quarter. Stevens Capital Management LP’s holdings in Clorox were worth $1,071,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. State Street Corp grew its stake in shares of Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after buying an additional 245,525 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after buying an additional 33,970 shares during the last quarter. Stifel Financial Corp grew its stake in shares of Clorox by 1.7% during the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after buying an additional 37,967 shares during the last quarter. Amundi grew its stake in shares of Clorox by 42.6% during the fourth quarter. Amundi now owns 1,032,283 shares of the company’s stock worth $165,816,000 after buying an additional 308,234 shares during the last quarter. Finally, FMR LLC grew its stake in shares of Clorox by 27.6% during the third quarter. FMR LLC now owns 776,232 shares of the company’s stock worth $126,456,000 after buying an additional 168,111 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $144.88 on Friday. The firm’s 50-day moving average price is $152.84 and its 200-day moving average price is $159.77. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The firm has a market capitalization of $17.85 billion, a P/E ratio of 39.58, a P/E/G ratio of 2.62 and a beta of 0.45. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the company earned $2.16 EPS. Equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.37%. Clorox’s dividend payout ratio is currently 133.33%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on CLX shares. DA Davidson decreased their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Barclays boosted their price objective on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Evercore ISI boosted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.